{
  "medical": "The response rates observed in the phase III trial were 45% for the investigational drug and 30% for placebo over a 12â€‘week period.",
  "layman": "About 45 out of 100 patients taking the new drug improved, compared with 30 out of 100 who took the placebo, after 12 weeks."
}